Advertisement
Advertisement

ALLK

ALLK logo

Allakos Inc

1.03
USD
-0.09
-8.04%
Jan 23, 15:58 UTC -5
Closed
...

Allakos Inc Profile

About

Allakos Inc. is a clinical stage bio-technology company. It discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory and proliferative diseases. Allakos Inc. is based in CA, United States.

Info & Links

CEO

Robert Alexander

Headquarters

825 Industrial Road, Suite 500
Redwood City, CA 94070, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

12

Employees

131

Allakos Inc Statistics

Valuation Measures

Market Capitalization2

92.02M

Enterprise Value

81.57M

Enterprise Value/EBITDA(ttm)

-0.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.36

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-140.87%

Return on Invested Capital(ttm)

-162.49%

Return on Assets(ttm)

-86.22%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-185.59M

Net Income Available to Common(ttm)

-178.75M

Diluted EPS(ttm)

-2.03

Share Statistics

Beta (5Y Monthly)

0.86

52-Week Change

-60.69%

S&P 500 52-Week Change

25.68%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

89.34M

Dividend Yield

0.00%

Float4

74.94M

% Held by Insiders

16.12%

% Held by Institutions

84.64%

Balance Sheet

Total Cash(mrq)

92.72M

Total Cash Per Share(mrq)

1.04

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.08%

Quick Ratio(mrq)

6.08%

Book Value Per Share(mrq)

0.81

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.91

Free Cash Flow(ytd)

-81.24M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement